InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Hume Daniel, Director. Director active across 1 company, notably TG Therapeutics, INC.. In total, 6 reports have been published. Activity tracked since 18 June 2021. The latest transaction was filed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hume Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
14,718 shares0Common StockSEC:0001437749-25-020541:0
62,459 shares0Common StockSEC:0001437749-25-008284:0
22,250 shares0Common StockSEC:0001437749-24-020850:0
20,000 shares0Common StockSEC:0001104659-23-105400:0
43,732 shares0Common StockSEC:0001104659-22-082022:0
20,000 shares0COMMON STOCKSEC:0001104659-21-084259:0
6 of 6 declarations
About Hume Daniel
Daniel Hume is a Director at TG THERAPEUTICS, INC. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the pharmaceutical sector and understanding of market challenges allow him to provide valuable insights during board discussions.
